- Home
- TMDX vs WSFS Comparison
TMDX vs WSFS Comparison
Compare TMDX & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- WSFS
- Stock Information
- Founded
- TMDX 1998
- WSFS 1980
- Country
- TMDX United States
- WSFS United States
- Employees
- TMDX N/A
- WSFS N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- WSFS Major Banks
- Sector
- TMDX Health Care
- WSFS Finance
- Exchange
- TMDX Nasdaq
- WSFS Nasdaq
- Market Cap
- TMDX 2.3B
- WSFS 2.7B
- IPO Year
- TMDX 2019
- WSFS N/A
- Fundamental
- Price
- TMDX $127.12
- WSFS $52.89
- Analyst Decision
- TMDX Buy
- WSFS Hold
- Analyst Count
- TMDX 10
- WSFS 4
- Target Price
- TMDX $122.89
- WSFS $61.00
- AVG Volume (30 Days)
- TMDX 1.1M
- WSFS 295.5K
- Earning Date
- TMDX 05-08-2025
- WSFS 07-24-2025
- Dividend Yield
- TMDX N/A
- WSFS 1.28%
- EPS Growth
- TMDX N/A
- WSFS N/A
- EPS
- TMDX 1.41
- WSFS 4.44
- Revenue
- TMDX $488,227,000.00
- WSFS $987,714,000.00
- Revenue This Year
- TMDX $32.58
- WSFS N/A
- Revenue Next Year
- TMDX $21.65
- WSFS $3.45
- P/E Ratio
- TMDX $90.86
- WSFS $12.01
- Revenue Growth
- TMDX 64.43
- WSFS 4.38
- 52 Week Low
- TMDX $55.00
- WSFS $42.21
- 52 Week High
- TMDX $177.37
- WSFS $62.75
- Technical
- Relative Strength Index (RSI)
- TMDX 76.52
- WSFS 49.32
- Support Level
- TMDX $118.79
- WSFS $51.75
- Resistance Level
- TMDX $130.48
- WSFS $54.22
- Average True Range (ATR)
- TMDX 4.49
- WSFS 1.36
- MACD
- TMDX -0.15
- WSFS -0.29
- Stochastic Oscillator
- TMDX 83.53
- WSFS 21.47
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.